rs121918106
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PS1_ModeratePP5_Very_Strong
The NM_002778.4(PSAP):c.1A>T(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000645 in 1,550,968 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000064 ( 0 hom. )
Consequence
PSAP
NM_002778.4 start_lost
NM_002778.4 start_lost
Scores
4
2
10
Clinical Significance
Conservation
PhyloP100: 3.45
Genes affected
PSAP (HGNC:9498): (prosaposin) This gene encodes a highly conserved preproprotein that is proteolytically processed to generate four main cleavage products including saposins A, B, C, and D. Each domain of the precursor protein is approximately 80 amino acid residues long with nearly identical placement of cysteine residues and glycosylation sites. Saposins A-D localize primarily to the lysosomal compartment where they facilitate the catabolism of glycosphingolipids with short oligosaccharide groups. The precursor protein exists both as a secretory protein and as an integral membrane protein and has neurotrophic activities. Mutations in this gene have been associated with Gaucher disease and metachromatic leukodystrophy. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
?
Start lost variant, no new inframe start found.
PS1
?
Another start lost variant in NM_002778.4 (PSAP) was described as [Pathogenic] in ClinVar as 860182
PP5
?
Variant 10-71851221-T-A is Pathogenic according to our data. Variant chr10-71851221-T-A is described in ClinVar as [Pathogenic]. Clinvar id is 13365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PSAP | NM_002778.4 | c.1A>T | p.Met1? | start_lost | 1/14 | ENST00000394936.8 | |
PSAP | NM_001042465.3 | c.1A>T | p.Met1? | start_lost | 1/15 | ||
PSAP | NM_001042466.3 | c.1A>T | p.Met1? | start_lost | 1/15 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PSAP | ENST00000394936.8 | c.1A>T | p.Met1? | start_lost | 1/14 | 1 | NM_002778.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00000657 AC: 1AN: 152258Hom.: 0 Cov.: 34
GnomAD3 genomes
?
AF:
AC:
1
AN:
152258
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000129 AC: 2AN: 154492Hom.: 0 AF XY: 0.0000245 AC XY: 2AN XY: 81696
GnomAD3 exomes
AF:
AC:
2
AN:
154492
Hom.:
AF XY:
AC XY:
2
AN XY:
81696
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000643 AC: 9AN: 1398710Hom.: 0 Cov.: 31 AF XY: 0.00000725 AC XY: 5AN XY: 689912
GnomAD4 exome
AF:
AC:
9
AN:
1398710
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
689912
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.00000657 AC: 1AN: 152258Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74390
GnomAD4 genome
?
AF:
AC:
1
AN:
152258
Hom.:
Cov.:
34
AF XY:
AC XY:
1
AN XY:
74390
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Gaucher disease due to saposin C deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Molecular Genetics, Royal Melbourne Hospital | Apr 01, 2022 | This sequence change in PSAP may cause a truncated or absent protein by altering the start codon of the coding sequence and is predicted to lead to the omission of a critical region of the protein (PMID: 17616409, 17919309; ClinVar: SCV001231459.2, SCV001590882.1). The highest population minor allele frequency in gnomAD v2.1 is 0.004% (3/74,284 alleles) in the European (non-Finnish) population. This variant has been detected in at least five individuals with PSAP-related disorders with prosaposin deficiency from three unrelated families. Of those individuals, three individuals were homozygous and two siblings were compound heterozygous for the variant and a variant of uncertain significance, confirmed in trans (PMID: 1371116, 15944902, 17919309). Patients with this variant have displayed saposin C deficiency or combined saposin deficiency in fibroblasts/cell extracts (PMID: 1371116, 20484222). Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as PATHOGENIC. Following criteria are met: PVS1_Strong, PM3, PP1_Moderate, PM2_Supporting, PP4. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2007 | - - |
Combined PSAP deficiency Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 2007 | - - |
Sphingolipid activator protein 1 deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Sep 21, 2023 | For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of the initiator codon alters PSAP gene expression (PMID: 20484222). ClinVar contains an entry for this variant (Variation ID: 13365). This variant is also known as M1L. Disruption of the initiator codon has been observed in individuals with PSAP-related conditions (PMID: 1371116, 17616409, 20484222). This variant is present in population databases (rs121918106, gnomAD 0.004%). This sequence change affects the initiator methionine of the PSAP mRNA. The next in-frame methionine is located at codon 76. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
Cadd
Benign
Dann
Benign
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D;D
MetaSVM
Benign
T
MutationTaster
Benign
A;A;A
PROVEAN
Benign
N;.;N
REVEL
Uncertain
Sift
Benign
T;.;T
Sift4G
Benign
T;T;T
Polyphen
P;.;.
Vest4
MutPred
Loss of solvent accessibility (P = 0.0152);Loss of solvent accessibility (P = 0.0152);Loss of solvent accessibility (P = 0.0152);
MVP
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at